DREADDs: novel tools for drug discovery and development

被引:70
作者
Lee, Hyeong-Min
Giguere, Patrick M.
Roth, Bryan L. [1 ]
机构
[1] Univ N Carolina, Div Chem Biol & Med Chem, Chapel Hill Med Sch, Dept Pharmacol, Chapel Hill, NC 27514 USA
关键词
PROTEIN-COUPLED RECEPTORS; DESIGNED G(I)-COUPLED RECEPTOR; FUNCTIONAL SELECTIVITY; CONDITIONAL EXPRESSION; SEROTONIN RECEPTORS; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; PATHWAYS; LIGANDS; TARGETS;
D O I
10.1016/j.drudis.2013.10.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Since the invention of the first designer receptors exclusively activated by designer drugs (DREADDs), these engineered G protein-coupled receptors (GPCRs) have been widely applied in investigations of biological processes and behaviors. DREADD technology has emerged as a powerful tool with great potential for drug discovery and development. DREADDs can facilitate the identification of druggable targets and enable researchers to explore the activities of novel drugs against both known and orphan GPCRs. Here, we discuss how DREADDs can be used as novel tools for drug discovery and development.
引用
收藏
页码:469 / 473
页数:5
相关论文
共 44 条
[1]   Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled Receptors [J].
Alexander, Georgia M. ;
Rogan, Sarah C. ;
Abbas, Atheir I. ;
Armbruster, Blaine N. ;
Pei, Ying ;
Allen, John A. ;
Nonneman, Randal J. ;
Hartmann, John ;
Moy, Sheryl S. ;
Nicolelis, Miguel A. ;
McNamara, James O. ;
Roth, Bryan L. .
NEURON, 2009, 63 (01) :27-39
[2]   Discovery of β-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy [J].
Allen, John A. ;
Yost, Julianne M. ;
Setola, Vincent ;
Chen, Xin ;
Sassano, Maria F. ;
Chen, Meng ;
Peterson, Sean ;
Yadav, Prem N. ;
Huang, Xi-ping ;
Feng, Bo ;
Jensen, Niels H. ;
Che, Xin ;
Bai, Xu ;
Frye, Stephen V. ;
Wetsel, William C. ;
Caron, Marc G. ;
Javitch, Jonathan A. ;
Roth, Bryan L. ;
Jin, Jian .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (45) :18488-18493
[3]   Strategies to Discover Unexpected Targets for Drugs Active at G Protein-Coupled Receptors [J].
Allen, John A. ;
Roth, Bryan L. .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011, 2011, 51 :117-144
[4]  
Analysts GI, 2012, G PROT COUPL REC GPC
[5]   Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand [J].
Armbruster, Blaine N. ;
Li, Xiang ;
Pausch, Mark H. ;
Herlitze, Stefan ;
Roth, Bryan L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (12) :5163-5168
[6]   TRIAL WATCH Phase III and submission failures: 2007-2010 [J].
Arrowsmith, John .
NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (02) :1-1
[7]   The Expanded Biology of Serotonin [J].
Berger, Miles ;
Gray, John A. ;
Roth, Bryan L. .
ANNUAL REVIEW OF MEDICINE, 2009, 60 :355-366
[8]   Automated design of ligands to polypharmacological profiles [J].
Besnard, Jeremy ;
Ruda, Gian Filippo ;
Setola, Vincent ;
Abecassis, Keren ;
Rodriguiz, Ramona M. ;
Huang, Xi-Ping ;
Norval, Suzanne ;
Sassano, Maria F. ;
Shin, Antony I. ;
Webster, Lauren A. ;
Simeons, Frederick R. C. ;
Stojanovski, Laste ;
Prat, Annik ;
Seidah, Nabil G. ;
Constam, Daniel B. ;
Bickerton, G. Richard ;
Read, Kevin D. ;
Wetsel, William C. ;
Gilbert, Ian H. ;
Roth, Bryan L. ;
Hopkins, Andrew L. .
NATURE, 2012, 492 (7428) :215-+
[9]   TRV120027, a Novel β-Arrestin Biased Ligand at the Angiotensin II Type I Receptor, Unloads the Heart and Maintains Renal Function When Added to Furosemide in Experimental Heart Failure [J].
Boerrigter, Guido ;
Soergel, David G. ;
Violin, Jonathan D. ;
Lark, Michael W. ;
Burnett, John C., Jr. .
CIRCULATION-HEART FAILURE, 2012, 5 (05) :627-634
[10]   Ligand discovery from a dopamine D3 receptor homology model and crystal structure [J].
Carlsson, Jens ;
Coleman, Ryan G. ;
Setola, Vincent ;
Irwin, John J. ;
Fan, Hao ;
Schlessinger, Avner ;
Sali, Andrej ;
Roth, Bryan L. ;
Shoichet, Brian K. .
NATURE CHEMICAL BIOLOGY, 2011, 7 (11) :769-778